PeproTech Inc.

This Article
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bermudez, L. E.
Right arrow Articles by Young, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bermudez, L. E.
Right arrow Articles by Young, L. S.

Journal of Leukocyte Biology, Vol 48, Issue 1 67-73, Copyright © 1990 by Society for Leukocyte Biology


JOURNAL ARTICLE

Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex

LE Bermudez and LS Young
Kuzell Institute for Arthritis and Infectious Diseases, Medical Research Institute of San Francisco Pacific Presbyterian Medical Center 94115-1896.

Organisms belonging to the Mycobacterium avium complex (MAC) are associated with life-threatening bacteremia in patients with the acquired immunodeficiency syndrome (AIDS). As these organisms survive within macrophages, we examined the ability of recombinant human granulocyte-monocyte colony-stimulating factor (GM-CSF) to activate human monocyte-derived macrophages to inhibit the intracellular growth or kill the most mouse-virulent MAC strain in our collection that belongs to serotype 1. While unstimulated cells did not inhibit intracellular growth of MAC, macrophages activated by GM-CSF (10-10(4) U/ml) inhibited or killed up to 58 +/- 5% of the initial inoculum. This activation was dose-dependent, with maximal change occurring with a dose of 100 U/ml after 72 hr exposure. Inhibition or killing was demonstrated if GM-CSF was given both before or after establishment of infection. The combination of GM-CSF (10(2) U/ml) plus TNF (10(2) U/ml) augmented macrophage killing (range, 31 +/- 4%) compared with GM-CSF (10(2) U/ml) alone, but the combination of recombinant human interferon-gamma (IFN gamma) plus GM-CSF resulted in a significant decrease in intracellular inhibition of growth or killing (13.3 +/- 2%) compared with 57.7 +/- 5% obtained with GM-CSF alone. These results indicate that: 1) GM-CSF can activate macrophages to inhibit intracellular growth or kill MAC; 2) killing may be augmented by TNF; and 3) IFN gamma may impair GM-CSF-dependent macrophage activation.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
N. Mohagheghpour, A. van Vollenhoven, J. Goodman, and L. E. Bermudez
Interaction of Mycobacterium avium with Human Monocyte-Derived Dendritic Cells
Infect. Immun., October 1, 2000; 68(10): 5824 - 5829.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. BONAY, F. BOUCHONNET, V. PELICIC, B. LAGIER, M. GRANDSAIGNE, D. LECOSSIER, A. GRODET, M. VOKURKA, B. GICQUEL, and A. J. HANCE
Effect of Stimulation of Human Macrophages on Intracellular Survival of Mycobacterium bovis Bacillus Calmette-Guerin . Evaluation with a Mycobacterial Reporter Strain
Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1629 - 1637.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. O. Armitage
Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
Blood, December 15, 1998; 92(12): 4491 - 4508.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. YONEDA and J. J. ELLNER
CD4+ T Cell and Natural Killer Cell-dependent Killing of Mycobacterium tuberculosis by Human Monocytes
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Via, R. Fratti, M McFalone, E Pagan-Ramos, D Deretic, and V Deretic
Effects of cytokines on mycobacterial phagosome maturation
J. Cell Sci., January 4, 1998; 111(7): 897 - 905.
[Abstract] [PDF]